Pediatrix Medical Group (NYSE:MD) Sheds US$108m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years
Pediatrix Medical Group (NYSE:MD) Sheds US$108m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years
Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. For example, we sympathize with anyone who was caught holding Pediatrix Medical Group, Inc. (NYSE:MD) during the five years that saw its share price drop a whopping 71%. We also note that the stock has performed poorly over the last year, with the share price down 42%. The falls have accelerated recently, with the share price down 18% in the last three months. But this could be related to the weak market, which is down 11% in the same period.
长期投资效果不错,但并不总是对每只股票都有效。我们不希望任何人遭受灾难性的资本损失。例如,我们同情任何被抓到持有儿科医疗集团。(纽约证券交易所代码:MD)在这五年中,其股价暴跌了71%。我们还注意到,该股在过去一年中表现不佳,股价下跌了42%。股价最近加速下跌,在过去三个月里下跌了18%。但这可能与疲软的市场有关,同期市场下跌了11%。
After losing 10% this past week, it's worth investigating the company's fundamentals to see what we can infer from past performance.
在过去一周下跌10%之后,有必要调查一下该公司的基本面,看看我们可以从过去的表现中推断出什么。
Check out our latest analysis for Pediatrix Medical Group
查看我们对儿科医疗集团的最新分析
While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
虽然有效市场假说继续被一些人传授,但事实证明,市场是过度反应的动态系统,投资者并不总是理性的。评估围绕一家公司的情绪变化的一个有缺陷但合理的方法是将每股收益(EPS)与股价进行比较。
Looking back five years, both Pediatrix Medical Group's share price and EPS declined; the latter at a rate of 21% per year. Notably, the share price has fallen at 22% per year, fairly close to the change in the EPS. That suggests that the market sentiment around the company hasn't changed much over that time. Rather, the share price has approximately tracked EPS growth.
回顾五年前,儿科医疗集团的股价和每股收益都出现了下降;后者以每年21%的速度下降。值得注意的是,该公司股价以每年22%的速度下跌,相当接近每股收益的变化。这表明,在这段时间里,围绕该公司的市场情绪没有太大变化。相反,该公司股价已大致追随每股收益的增长。
You can see below how EPS has changed over time (discover the exact values by clicking on the image).
您可以在下面看到EPS是如何随着时间的推移而变化的(通过单击图像来了解确切的值)。
![earnings-per-share-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231029/0-0dca5cba2f72015627f630ee3da30031-0-12d720f8bfaba56e89dbcc1899bb8c04.png/big)
We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here..
我们很高兴地报告,这位首席执行官的薪酬比类似资本公司的大多数首席执行官都要低。关注首席执行官的薪酬总是值得的,但更重要的问题是,该公司是否会在未来几年实现盈利增长。在买卖股票之前,我们总是建议仔细检查一下历史增长趋势,可在此处找到。
A Different Perspective
不同的视角
While the broader market gained around 6.1% in the last year, Pediatrix Medical Group shareholders lost 42%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 11% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 1 warning sign we've spotted with Pediatrix Medical Group .
尽管大盘去年上涨了约6.1%,但Pediatrix Medical Group的股东下跌了42%。然而,请记住,即使是最好的股票,在12个月的时间里,有时也会表现逊于市场。不幸的是,去年的表现可能预示着尚未解决的挑战,因为它比过去五年11%的年化损失更糟糕。一般来说,股价长期疲软可能是一个坏信号,尽管反向投资者可能会希望研究这只股票,希望它能好转。我发现,把股价作为衡量企业业绩的长期指标是非常有趣的。但为了真正获得洞察力,我们还需要考虑其他信息。为此,您应该意识到1个警告标志我们发现了儿科医疗集团。
Of course Pediatrix Medical Group may not be the best stock to buy. So you may wish to see this free collection of growth stocks.
当然了儿科医疗集团可能不是最值得买入的股票。所以你可能想看看这个免费成长型股票的集合。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.
请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对这篇文章有什么反馈吗?担心内容吗? 保持联系直接与我们联系。或者,也可以给编辑组发电子邮件,地址是implywallst.com。
本文由Simply Wall St.撰写,具有概括性。我们仅使用不偏不倚的方法提供基于历史数据和分析师预测的评论,我们的文章并不打算作为财务建议。它不构成买卖任何股票的建议,也没有考虑你的目标或你的财务状况。我们的目标是为您带来由基本面数据驱动的长期重点分析。请注意,我们的分析可能不会将最新的对价格敏感的公司公告或定性材料考虑在内。Simply Wall St.对上述任何一只股票都没有持仓。